First human test for new obesity pill begins
NCT ID NCT07223216
First seen Nov 01, 2025 · Last updated Apr 20, 2026 · Updated 21 times
Summary
This is an early-stage study to check the safety and side effects of a new drug called BMF-650 in people who are overweight or obese. The study will enroll 80 otherwise healthy participants to receive either the drug or a placebo. The main goal is to see how the body processes the drug and to identify any potential safety issues before larger trials can begin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medpace Clinical Pharmacology
Cincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.